[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580790":3},{"organization":4,"armGroups":7,"interventions":34,"overallOfficials":40,"centralContacts":45,"locations":54,"responsibleParty":74,"collaborators":10,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":84,"sex":85,"minAge":86,"maxAge":87,"enrollmentInfo":88,"targetDuration":10,"studyType":91,"phases":10,"briefSummary":92,"conditions":93,"keywords":96,"overallStatus":57,"whyStopped":10,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Mario Negri Institute for Pharmacological Research","OTHER",[8,14,18,22,26,30],{"label":9,"type":10,"description":11,"interventionNames":12},"Males, age group 1",null,"Male subjects aged 18-40 years",[13],"Diagnostic Test: US acquisitions",{"label":15,"type":10,"description":16,"interventionNames":17},"Males, age group 2","Male subjects aged 41-55 years",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Males, age group 3","Male subjects aged 56-75 years",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Female, age group 1","Female subjects aged 18-40 years",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Females, age group 2","Female subjects aged 41-55 years",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"Females, age group 3","Female subjects aged 56-75 years",[13],[35],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":10},"DIAGNOSTIC_TEST","US acquisitions","US acquisition from two anatomical regions i.e., the non-dominant arm and the neck.",[23,27,31,9,15,19],[41],{"name":42,"affiliation":43,"role":44},"Giuseppe Remuzzi, M.D.","Istituto Di Ricerche Farmacologiche Mario Negri","STUDY_DIRECTOR",[46,51],{"name":47,"role":48,"phone":49,"phoneExt":10,"email":50},"Michela Bozzetto, Ph.D.","CONTACT","+39 035 4535 381","michela.bozzetto@marionegri.it",{"name":52,"role":48,"phone":49,"phoneExt":10,"email":53},"Luca Soliveri","luca.soliveri@marionegri.it",[55],{"facility":56,"status":57,"city":58,"state":59,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":68,"contacts":69},"Clinical Research Centre for Rare Diseases Aldo e Cele Daccò","RECRUITING","Ranica","BG","24020","Italy","IT",{"type":64,"coordinates":65},"Point",[66,67],9.71335,45.72328,{"lat":67,"lon":66},[70],{"name":71,"role":48,"phone":72,"phoneExt":10,"email":73},"Matias Trillini, M.D.","+39 035 4535 411","matias.trillini@marionegri.it",{"type":75,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100580790","new-advanced-vascular-imaging-ultrasound-protocols-100580790",false,"NCT06841887","New Advanced Vascular Imaging Ultrasound Protocols","Unlock the Power of Resona 9 Ultrasound Machine: an Observational Study to Set-up and Test New Advanced Vascular Imaging Protocols","RESONA-SETTING","Inclusion Criteria:\n\n* Provision of informed consent prior to any study specific procedures\n* Female and\u002For male aged between 18 and 75 years\n* No previous history of kidney or cerebral disease and no pathologies that might have affected the vascular system\n\nExclusion Criteria:\n\n* Previous history of kidney or cerebral disease or pathologies that might have affected the vascular system\n* Legal incapacity, limited legal capacity, intellectual disability, uncooperative attitude or any other evidence that the subject will not be able to understand the study aims and procedures",true,"ALL","18 Years","75 Years",{"count":89,"type":90},60,"ESTIMATED","OBSERVATIONAL","This is a single-center observational study aimed at setting up and testing new ultrasound vascular imaging protocols, conducted exclusively for research purposes. The study will perform US examinations in 60 subjects. The subjects enrolled in the study will be examined the first time and will then provide consent to be examined again in the future if needed.\n\nThe primary aim of this study is to set-up and test new advanced US protocol for the arm and cerebral blood vessels\n\nThe secondary objectives will be:\n\n* Define ranges of normality\u002Freference values of US-based parameters to be compared with pathological values.\n* Evaluate the repeatability and reproducibility of the acquired US measurements.\n* Evaluate the correlation between age and the acquired US measurements.\n* Evaluate the correlation between gender and the acquired US measurements.",[94,95],"Renal Diseases","Cerebral Disorder",[97,98,99],"ultrasound","imaging","vascular protocol","2025-08-28",{"date":102,"type":103},"2025-09-05","ACTUAL",{"date":105,"type":103},"2025-05-09",{"date":107,"type":90},"2027-03",{"name":5,"class":6},1]